Pulmonology

On this page

🫁 The Respiratory Arsenal: Mastering Pulmonary Medicine

You'll master the complete architecture of respiratory medicine-from airway anatomy through gas exchange mechanics to pattern recognition of clinical presentations. This lesson builds your diagnostic reasoning by connecting structural foundations with pathophysiology, then equips you with evidence-based investigation strategies and therapeutic protocols. You'll learn to recognize how pulmonary disease intersects with cardiac, renal, and metabolic systems, developing the rapid assessment frameworks essential for clinical decision-making. By integrating anatomy, physiology, and clinical reasoning, you'll gain the confidence to approach any respiratory case systematically and effectively.

Detailed anatomical illustration of complete respiratory system showing airways, alveoli, and pulmonary circulation

Pulmonary medicine encompasses the intricate network of airways, gas exchange surfaces, and vascular systems that sustain life through every breath. Master these respiratory territories, and you possess the foundation for diagnosing everything from simple bronchitis to complex interstitial lung diseases.

Clinical Pearl: The respiratory system processes >20,000 breaths daily, moving >10,000 liters of air through 300 million alveoli with a combined surface area of 70 square meters - equivalent to a tennis court.

Understanding pulmonary pathophysiology requires systematic integration of anatomy, physiology, and clinical correlation. Every respiratory symptom follows predictable patterns based on anatomical involvement and physiological disruption.

📌 Remember: BREATHE for respiratory assessment - Breathing pattern, Respiratory rate, Expansion symmetry, Accessory muscle use, Tactile fremitus, Heart sounds, Exercise tolerance

The respiratory system's complexity demands structured approaches to diagnosis and management. From obstructive patterns with FEV1/FVC <70% to restrictive diseases with TLC <80% predicted, quantitative thresholds guide clinical decision-making.

💡 Master This: Respiratory failure occurs when PaO2 <60 mmHg or PaCO2 >50 mmHg with pH <7.35, but clinical context determines intervention urgency more than absolute numbers.

Connect respiratory fundamentals through systematic disease patterns to understand how anatomical disruption creates predictable clinical presentations across the pulmonary medicine spectrum.


🫁 The Respiratory Arsenal: Mastering Pulmonary Medicine

🌬️ The Airway Architecture: Foundation of Respiratory Function

Cross-sectional anatomy of bronchial tree showing generational branching from trachea to alveoli

The conducting airways (generations 0-16) provide airflow pathways without gas exchange, while respiratory zones (generations 17-23) facilitate oxygen and carbon dioxide transfer. Understanding this anatomical hierarchy explains disease patterns and treatment targeting.

📌 Remember: CONDUCTING airways - Cartilage support, Only air movement, No gas exchange, Deadspace volume 150 mL, Upper 16 generations, Ciliary clearance, Trachea to terminal bronchioles, Innervated autonomically, Narrow progressively, Goblet cells present

Airway GenerationStructureDiameter (mm)FunctionClinical Relevance
0-4Trachea-Main bronchi18-12Air conductionCentral obstruction causes stridor
5-11Lobar-Segmental bronchi8-3Air distributionBronchiectasis commonly affects
12-16Terminal bronchioles1-0.5Final conductionAsthma primarily targets
17-19Respiratory bronchioles0.4-0.3Initial gas exchangeEmphysema destroys walls
20-23Alveolar ducts/sacs0.2-0.1Primary gas exchangePneumonia fills spaces
  • Upper Airways (Generations 0-8)
    • Cartilaginous support maintains patency
    • Pseudostratified ciliated epithelium with goblet cells
    • Mucociliary escalator clears 1-2 cm/minute
      • Normal mucus production: 100 mL/day
      • Increased in disease: >500 mL/day
  • Lower Airways (Generations 9-16)
    • Smooth muscle increases proportionally
    • Clara cells produce surfactant precursors
    • Autonomic innervation predominates
      • Sympathetic: β2-receptors → bronchodilation
      • Parasympathetic: M3-receptors → bronchoconstriction

Clinical Pearl: Airway resistance follows Poiseuille's law - resistance ∝ 1/radius⁴, so 50% diameter reduction increases resistance 16-fold, explaining why small airway inflammation causes dramatic symptoms.

💡 Master This: The "equal pressure point" during forced expiration moves peripherally in COPD, causing dynamic airway collapse and flow limitation independent of expiratory effort - explaining why COPD patients cannot "blow harder" to improve flow.

Understanding airway anatomy reveals why different diseases target specific generations and respond to particular interventions, forming the foundation for systematic respiratory disease management.


🌬️ The Airway Architecture: Foundation of Respiratory Function

⚙️ The Gas Exchange Engine: Alveolar-Capillary Interface Mastery

📌 Remember: MEMBRANE components - Microscopic thickness 0.5μm, Epithelial type I cells, Membrane basement fusion, Blood-gas barrier, Red cell transit 0.25s, Alveolar surface 70m², Normal diffusion capacity, Endothelial capillary lining

Gas exchange efficiency depends on ventilation-perfusion (V/Q) matching, with normal ratio 0.8-1.0. Mismatching creates physiological shunting and dead space ventilation, fundamental concepts in respiratory pathophysiology.

Gas Exchange ParameterNormal ValueClinical SignificanceDisease Correlation
Alveolar surface area70 m²Determines diffusion capacity↓ in emphysema, fibrosis
Membrane thickness0.5 μmAffects diffusion rate↑ in pulmonary edema
Capillary transit time0.25 secondsLimits gas equilibration↓ in exercise, disease
V/Q ratio0.8-1.0Optimal gas exchangeAltered in most lung diseases
DLCO25-30 mL/min/mmHgOverall diffusion capacity↓ in ILD, emphysema
  • Ultra-thin cytoplasm enables gas diffusion
  • Tight junctions prevent fluid leak
  • Cannot regenerate after injury
    • Damage leads to type II cell proliferation
    • Repair may cause fibrosis
  • Type II Pneumocytes (5% surface area)
    • Produce surfactant (phosphatidylcholine 70%)
    • Stem cell function for alveolar repair
    • Metabolically active with lamellar bodies
      • Surfactant reduces surface tension from 70 to 25 dynes/cm
      • Prevents alveolar collapse at low volumes

Electron microscopy of type II pneumocyte showing lamellar bodies and surfactant production

Clinical Pearl: Fick's law governs gas diffusion: Rate ∝ (Surface Area × Pressure Gradient) / (Membrane Thickness × Molecular Weight). This explains why CO diffusion (MW 28) tests membrane integrity better than O₂ (MW 32).

Ventilation-perfusion relationships determine gas exchange efficiency through gravitational and pathological influences. In upright position, V/Q ratio varies from 3.0 at apex to 0.6 at base, creating physiological dead space and shunt.

💡 Master This: The A-a gradient normally <15 mmHg in young adults, increasing 2.5 mmHg per decade. Elevation indicates V/Q mismatch, diffusion limitation, or right-to-left shunting - distinguishing pulmonary from cardiac causes of hypoxemia.

Connect gas exchange principles through pathophysiological disruptions to understand how diseases create predictable patterns of hypoxemia, hypercapnia, and respiratory failure.


⚙️ The Gas Exchange Engine: Alveolar-Capillary Interface Mastery

🎯 The Pattern Recognition Matrix: Clinical Presentation Frameworks

📌 Remember: DYSPNEA pattern analysis - Duration (acute vs chronic), Young vs elderly, Smoking history, Positional changes, Nocturnal symptoms, Exercise limitation, Associated symptoms, Auscultatory findings

Clinical PatternKey FeaturesDiagnostic TestsSensitivity/Specificity
ObstructiveExpiratory wheeze, prolonged expirationFEV1/FVC <70%95%/90%
RestrictiveInspiratory crackles, reduced expansionTLC <80% predicted90%/95%
VascularSudden onset, pleuritic painD-dimer >500 ng/mL85%/50%
InfectiousFever, purulent sputumChest X-ray infiltrates80%/70%
MalignantWeight loss, hemoptysisCT chest abnormalities90%/85%
  • Pulmonary embolism: sudden onset, pleuritic pain, tachycardia >100
  • Pneumothorax: sharp chest pain, reduced breath sounds unilaterally
  • Acute asthma: expiratory wheeze, accessory muscle use, peak flow <50%
    • Severe: cannot speak full sentences
    • Life-threatening: silent chest, pulsus paradoxus >25 mmHg
  • Chronic Dyspnea Patterns (Weeks to Months)
    • COPD: smoking history, barrel chest, FEV1/FVC <70%
    • Interstitial lung disease: dry cough, fine crackles, DLCO <80%
    • Heart failure: orthopnea, S3 gallop, BNP >400 pg/mL
      • Pulmonary edema: bilateral crackles, frothy sputum
      • Right heart failure: peripheral edema, elevated JVP

Clinical Pearl: The "orthopnea grade" quantifies heart failure severity: Grade 1 = 3+ pillows, Grade 2 = 2 pillows, Grade 3 = 1 pillow, Grade 4 = cannot lie flat. Each grade correlates with NYHA functional class and ejection fraction ranges.

Physical examination findings provide immediate diagnostic clues with high specificity when properly interpreted. Combining multiple findings increases diagnostic accuracy exponentially.

  • High-Yield Auscultatory Patterns
    • Fine crackles: Interstitial disease, early CHF (sensitivity 80%)
    • Coarse crackles: Pneumonia, advanced CHF (specificity 85%)
    • Expiratory wheeze: Asthma, COPD (sensitivity 90% for obstruction)
      • Inspiratory wheeze: Upper airway obstruction, severe asthma
      • Stridor: Central airway obstruction (emergency evaluation)
    • Pleural friction rub: Pleuritis, malignancy (specificity 95%)

💡 Master This: Pulsus paradoxus >10 mmHg indicates severe airway obstruction or cardiac tamponade. In asthma, >25 mmHg suggests life-threatening attack requiring immediate intervention, while >40 mmHg may indicate impending respiratory arrest.

Understanding clinical patterns enables rapid triage and appropriate diagnostic testing, forming the foundation for efficient respiratory medicine practice and optimal patient outcomes.


🎯 The Pattern Recognition Matrix: Clinical Presentation Frameworks

🔬 The Diagnostic Arsenal: Evidence-Based Investigation Strategies

📌 Remember: IMAGING sequence - Initial chest X-ray, Modality selection (CT/MRI), Angiography if vascular, Guided biopsy procedures, Interventional options, Nuclear medicine studies, Genetic testing when indicated

Diagnostic TestSensitivitySpecificityBest Clinical UseCost-Effectiveness
Chest X-ray70-80%85-90%Initial screeningHigh
CT chest90-95%80-85%Detailed evaluationModerate
PFTs85-90%90-95%Functional assessmentHigh
Bronchoscopy80-90%95-98%Tissue diagnosisLow
CTPA95-98%90-95%Pulmonary embolismModerate
  • Chest X-ray: $50-100, identifies 70% of significant pathology
  • Pulse oximetry: $5-10, screens for hypoxemia >95% accuracy
  • Basic metabolic panel: $25-50, assesses acid-base status
    • Anion gap >12: Suggests metabolic acidosis
    • HCO3 <22: Compensatory or primary metabolic acidosis
  • Advanced Imaging Strategies
    • High-resolution CT (HRCT): $500-800, >95% sensitivity for ILD
    • CT pulmonary angiogram (CTPA): $800-1200, 98% sensitivity for PE
    • Ventilation-perfusion scan: $400-600, preferred in pregnancy, renal failure
      • High probability: >80% chance of PE
      • Low probability: <20% chance of PE

High-resolution CT scan showing honeycombing pattern characteristic of usual interstitial pneumonia

Pulmonary function testing provides objective assessment of respiratory mechanics and gas exchange, with specific patterns indicating disease categories and severity.

  • Spirometry Interpretation
    • FEV1/FVC <70%: Obstructive pattern (COPD, asthma)
    • FVC <80% predicted: Restrictive pattern (ILD, chest wall disease)
    • Bronchodilator response >12% and 200 mL: Suggests reversible obstruction
      • Asthma: Usually >15% improvement
      • COPD: Typically <12% improvement
  • Advanced PFT Parameters
    • DLCO <80% predicted: Impaired gas exchange (emphysema, ILD)
    • Total lung capacity (TLC): Distinguishes restriction from poor effort
    • Residual volume (RV): Elevated in air trapping (>120% predicted)

Spirometry flow-volume loops comparing normal, obstructive, and restrictive patterns

Clinical Pearl: D-dimer has >95% negative predictive value for PE when <500 ng/mL in low-risk patients, but positive predictive value <50% due to elevation in multiple conditions including infection, malignancy, and pregnancy.

Invasive diagnostic procedures require careful risk-benefit analysis and appropriate patient selection to maximize diagnostic yield while minimizing complications.

💡 Master This: Bronchoscopy diagnostic yield varies by indication: >90% for endobronchial lesions, 70-80% for peripheral nodules >2 cm, <50% for nodules <1 cm. Transbronchial biopsy carries 5-10% pneumothorax risk, requiring post-procedure chest X-ray.

Connect diagnostic strategies through evidence-based algorithms to develop systematic approaches that optimize accuracy, efficiency, and patient safety in respiratory medicine practice.


🔬 The Diagnostic Arsenal: Evidence-Based Investigation Strategies

🎛️ The Treatment Command Center: Therapeutic Mastery Protocols

📌 Remember: THERAPY principles - Targeted mechanism, Hierarchical approach, Evidence-based dosing, Response monitoring, Adverse effect surveillance, Patient education, Yield optimization

Therapeutic ClassMechanismOnset TimeDurationClinical Efficacy
SABA (Albuterol)β2-agonist5-15 minutes4-6 hours85% bronchodilation
LABA (Salmeterol)β2-agonist30-60 minutes12 hours70% symptom control
ICS (Fluticasone)Anti-inflammatory2-4 weeks12-24 hours60% exacerbation reduction
LAMA (Tiotropium)Anticholinergic30 minutes24 hours75% COPD control
Systemic steroidsAnti-inflammatory4-6 hoursVariable90% acute response
  • Short-acting β2-agonists (SABA): Albuterol 2.5-5 mg nebulized
    • Onset: 5-15 minutes, peak: 30-60 minutes
    • Rescue therapy: 2-4 puffs q4-6h PRN
    • Acute exacerbation: Continuous nebulization if severe
  • Long-acting β2-agonists (LABA): Never monotherapy in asthma
    • Salmeterol 50 μg BID or Formoterol 12 μg BID
    • Combination with ICS: Reduces exacerbations 40-50%
  • Anti-inflammatory Strategies
    • Inhaled corticosteroids (ICS): First-line controller therapy
      • Low dose: Fluticasone 100-250 μg/day
      • Medium dose: 250-500 μg/day
      • High dose: >500 μg/day (monitor for systemic effects)
    • Systemic corticosteroids: Prednisolone 0.5-1 mg/kg/day
      • Acute asthma: 40-60 mg daily × 5-7 days
      • COPD exacerbation: 30-40 mg daily × 5 days

Oxygen therapy requires precise titration based on underlying pathophysiology, with different targets for acute versus chronic conditions and specific monitoring parameters.

  • Oxygen Therapy Protocols
    • Acute hypoxemia: Target SpO2 94-98% (normal lungs)
    • COPD patients: Target SpO2 88-92% (avoid CO2 retention)
    • Delivery systems: Nasal cannula 1-6 L/min, Venturi mask 24-60%
      • High-flow nasal cannula: Up to 60 L/min, 21-100% FiO2
      • Non-invasive ventilation: BiPAP for hypercapnic failure
  • Advanced Respiratory Support
    • Mechanical ventilation indications: pH <7.25, PaCO2 >60 mmHg with acidosis
    • Lung-protective ventilation: Tidal volume 6-8 mL/kg ideal body weight
    • PEEP titration: 5-15 cmH2O based on oxygenation and compliance

Clinical Pearl: Inhaler technique errors occur in >70% of patients, reducing drug delivery by 50-90%. Spacer devices improve lung deposition from 10-15% to 20-30% and reduce oropharyngeal side effects.

Combination therapy strategies follow evidence-based guidelines with specific sequencing and monitoring requirements to optimize outcomes while minimizing polypharmacy risks.

💡 Master This: Step-up therapy in asthma follows GINA guidelines: Step 1 (SABA PRN) → Step 2 (Low-dose ICS) → Step 3 (ICS/LABA) → Step 4 (Medium/high-dose ICS/LABA) → Step 5 (Add LAMA, biologics, or oral steroids).

Understanding therapeutic protocols enables systematic treatment approaches that maximize efficacy, minimize adverse effects, and improve long-term respiratory outcomes across diverse pulmonary conditions.


🎛️ The Treatment Command Center: Therapeutic Mastery Protocols

🧠 The Integration Network: Multi-System Respiratory Connections

📌 Remember: SYSTEMS integration - Systemic circulation coupling, Young vs elderly responses, Sensory chemoreceptor feedback, Tissue oxygen delivery, Endocrine hormone interactions, Metabolic acid-base balance, Sympathetic nervous system activation

System IntegrationMechanismClinical ManifestationQuantitative Threshold
CardiovascularHypoxic pulmonary vasoconstrictionCor pulmonalePaO2 <60 mmHg chronically
NeurologicalCentral chemoreceptor responseAltered mental statusPaCO2 >50 mmHg acutely
RenalBicarbonate retention/excretionMetabolic compensationpH 7.35-7.45 maintenance
HematologicErythropoietin stimulationSecondary polycythemiaHgb >16 g/dL (men), >14 g/dL (women)
MetabolicOxygen consumption changesExercise intoleranceVO2 max <85% predicted
  • Hypoxic pulmonary vasoconstriction: PaO2 <60 mmHg triggers vasoconstriction
    • Acute response: Optimizes V/Q matching
    • Chronic response: Leads to pulmonary hypertension (mPAP >25 mmHg)
  • Right heart adaptation: Cor pulmonale develops with sustained pressure elevation
    • Compensated: Normal cardiac output at rest
    • Decompensated: Elevated JVP, peripheral edema, hepatomegaly
  • Neurological-Respiratory Integration
    • Central chemoreceptors (medulla): Respond to CSF pH changes from CO2
      • Primary drive: 80% of respiratory stimulus at rest
      • Blunted response: In chronic hypercapnia (COPD)
    • Peripheral chemoreceptors (carotid/aortic bodies): Respond to PaO2 <60 mmHg
      • Hypoxic drive: Becomes primary in chronic CO2 retention
      • Oxygen therapy: Can suppress drive in COPD patients

Diagram showing respiratory control centers and chemoreceptor feedback loops

Acid-base integration demonstrates sophisticated physiological compensation mechanisms that maintain pH homeostasis through respiratory and renal adjustments with specific time courses and quantitative relationships.

  • Respiratory Acid-Base Compensation
    • Metabolic acidosis: Hyperventilation within minutes
      • Expected PaCO2 = 1.5 × [HCO3] + 8 ± 2
      • Winter's formula: Predicts appropriate compensation
    • Metabolic alkalosis: Hypoventilation limited by hypoxemia
      • PaCO2 rarely exceeds 55 mmHg due to hypoxic drive
      • Compensation: 0.7 mmHg rise per 1 mEq/L HCO3 increase
  • Renal Respiratory Compensation
    • Respiratory acidosis: HCO3 retention over days
      • Acute: 1 mEq/L rise per 10 mmHg PaCO2 increase
      • Chronic: 3.5 mEq/L rise per 10 mmHg PaCO2 increase
    • Respiratory alkalosis: HCO3 excretion over days
      • Acute: 2 mEq/L fall per 10 mmHg PaCO2 decrease
      • Chronic: 5 mEq/L fall per 10 mmHg PaCO2 decrease

Blood gas analysis chart showing acid-base disorders and compensation patterns

Clinical Pearl: Sleep-disordered breathing affects >30% of heart failure patients, creating bidirectional pathophysiology where OSA worsens heart failure through increased afterload and heart failure worsens OSA through fluid shifts and central apneas.

Hematologic adaptations to chronic hypoxemia involve erythropoietin-mediated responses that can become maladaptive, requiring careful monitoring and intervention strategies.

💡 Master This: Secondary polycythemia from chronic hypoxemia improves oxygen delivery initially but becomes detrimental when hematocrit >55% due to increased viscosity. Phlebotomy may be indicated when symptoms occur with hematocrit >60%.

Understanding multi-system integration enables comprehensive management approaches that address respiratory diseases within the context of overall physiological homeostasis and comorbid conditions.


🧠 The Integration Network: Multi-System Respiratory Connections

🎯 The Clinical Mastery Toolkit: Rapid Assessment and Decision Frameworks

📌 Remember: MASTERY framework - Multi-system assessment, Algorithmic thinking, Severity stratification, Treatment prioritization, Evidence integration, Risk-benefit analysis, Yield optimization

Clinical ScenarioRapid Assessment ToolsCritical ThresholdsImmediate Actions
Acute dyspneaCURB-65, Wells scoreSpO2 <90%, RR >30Oxygen, imaging, labs
Asthma exacerbationPeak flow, accessory musclesPEF <50%, silent chestBronchodilators, steroids
COPD exacerbationABG, mental statuspH <7.35, altered LOCNIV, antibiotics
Suspected PEWells score, D-dimerHigh probability >6Anticoagulation, CTPA
Respiratory failureABG, work of breathingpH <7.25, fatigueVentilatory support
  • Normal values: RR 12-20, SpO2 >95%, PaO2 >80 mmHg, PaCO2 35-45 mmHg
  • Critical thresholds: SpO2 <90%, PaO2 <60 mmHg, pH <7.30, RR >30
  • Severity markers: Accessory muscle use, inability to speak, altered mental status
    • Mild distress: Speaks full sentences, RR <25
    • Moderate distress: Speaks phrases, RR 25-35
    • Severe distress: Single words only, RR >35

Clinical Pearl: The "Rule of 30s" identifies respiratory failure: RR >30, PaO2 <30 mmHg on room air, A-a gradient >30 mmHg, or FiO2 requirement >30% to maintain adequate oxygenation.

💡 Master This: Pattern recognition mastery combines anatomical knowledge + physiological understanding + clinical experience to achieve diagnostic accuracy >95% in respiratory medicine. Systematic approaches prevent cognitive errors and optimize patient outcomes across diverse presentations.

🎯 The Clinical Mastery Toolkit: Rapid Assessment and Decision Frameworks

Practice Questions: Pulmonology

Test your understanding with these related questions

Which class of bronchodilators is considered the most effective for managing chronic obstructive pulmonary disease (COPD)?

1 of 5

Flashcards: Pulmonology

1/10

The arterial blood profile seen in compensated respiratory acidosis is: pH: _____[HCO3-]: increasedPCO2: increased

TAP TO REVEAL ANSWER

The arterial blood profile seen in compensated respiratory acidosis is: pH: _____[HCO3-]: increasedPCO2: increased

decreased

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial